Iceland pushes forward with electronic leaflets
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Introducing electronic patient information leaflets (e-PILs) across Europe would improve patient safety and make trade easier between European countries, according to Einar Magnússon, Iceland’s representative on the Council of Europe’s pharmaceuticals and pharmaceutical care committee, the CD-P-PH.
You may also be interested in...
AESGP Conference Round-Up: Digital Disruption, Med Device Worries And The Benefits Of Switching
Speakers from the EMA and European Commission, as well as Pfizer and HRA Pharma, debated at the AESGP's Regulatory Conference the ongoing digital transformation of the European consumer healthcare market, the latest developments in the implementation of the new medical devices regulations, and the best ways to encourage Rx-to-OTC switching across the EU.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.